BeautyBio has closed on a minority investment from Kainos, a Dallas-based private equity firm.
Jamie O’Banion with GloPro’s rose quartz roller attachment.
BeautyBio, best known for its GloPro microneedling devices, plans to use the funds to continue product development and global expansion, according to founder and chief executive officer Jamie O’Banion.
“They’re not a traditional beauty fund, which is something that I loved because we want to make sure we’re always meaningful to whoever we partner with,” O’Banion said, referencing the firm’s current lack of other beauty investments. “Because we’re scaling right now it’s less about having someone that is able to make an introduction…What I need is someone who’s an operational expert.”
BeautyBio anticipates freight shipping and digital expertise will come from the firm, O’Banion said
BeautyBio straddles both skin-care devices with its rolling tools and skin-care with its product line. According to O’Banion, the brand is able to successfully do both because it started in skin care first, before launching GloPro. “I had to convince people as a skin-care expert why they should incorporate a tool — it’s a totally different approach,” she said.
“A woman doesn’t care if she’s using a microneedling tool, a Vitamin A cream, an ingestible beauty drink — she